349 related articles for article (PubMed ID: 10458038)
1. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
Sidorenko SV; Gel'fand EB; Mamontova OA
Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
[TBL] [Abstract][Full Text] [Related]
2. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
4. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
Eagye KJ; Banevicius MA; Nicolau DP
Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
Yüce A; Yapar N; Eren Kutsoylu O
Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
8. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
9. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibility of Pseudomonas aeruginosa isolated from hospital infections to antibiotics].
Gniadkowski M; Skoczyńska A; Fiett J; Trzciński K; Hryniewicz W
Pol Merkur Lekarski; 1998 Dec; 5(30):346-50. PubMed ID: 10101521
[TBL] [Abstract][Full Text] [Related]
11. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
[TBL] [Abstract][Full Text] [Related]
12. Update on the treatment of Pseudomonas aeruginosa pneumonia.
El Solh AA; Alhajhusain A
J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
[TBL] [Abstract][Full Text] [Related]
13. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.
Juan C; Gutiérrez O; Oliver A; Ayestarán JI; Borrell N; Pérez JL
Clin Microbiol Infect; 2005 Nov; 11(11):887-92. PubMed ID: 16216103
[TBL] [Abstract][Full Text] [Related]
14. [In vitro study of the sensitivity to antibiotics of 213 Pseudomonas aeruginosa strains isolated in an intensive care unit of the Sfax Hospital (Tunisia)].
Karray H; Hammami A; Mahjoubi F; Bouaziz M; Damak J; Jeddi HM
Pathol Biol (Paris); 1993 Apr; 41(4):307-12. PubMed ID: 8233627
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
16. [Multi-drug resistant Pseudomonas aeruginosa: towards a therapeutic dead end?].
Barbier F; Wolff M
Med Sci (Paris); 2010 Nov; 26(11):960-8. PubMed ID: 21106178
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
[TBL] [Abstract][Full Text] [Related]
18. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
Tsukayama DT; van Loon HJ; Cartwright C; Chmielewski B; Fluit AC; van der Werken C; Verhoef J;
Int J Antimicrob Agents; 2004 Oct; 24(4):339-45. PubMed ID: 15380258
[TBL] [Abstract][Full Text] [Related]
19. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
20. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
Vanni M; Zucca C
Minerva Med; 1986 Jun; 77(27):1289-92. PubMed ID: 3088493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]